Frontlight ResearchEarly access
Trial site
The First Hospital of Harbin
- 2running trials
- 3closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Acute lymphoblastic leukaemia2 trials
- Coronary artery disease1 trial
- Follicular lymphoma1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 22 trials
- Phase 42 trials
- Phase 1/21 trial
- Status
- Completed3 trials
- Not yet recruiting2 trials
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- Harbin Medical University1 trial
- Hutchison Medipharma Limited1 trial
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.1 trial
- Pfizer1 trial
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026